contadores web
Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Scientific and technological research article

Vol. 23 No. 2 (2021)

Quality of life related to health, anxiety and depression in people with cardioverter defibrillators

DOI
https://doi.org/10.22267/rus.212302.222
Submitted
April 17, 2020
Published
2021-04-30

Abstract

Introduction: Cardiovascular diseases have caused a rise in arrhythmias, increasing the use caridoverter defibrillators. Although, these devices prevent arrhythmias, they may also affect the quality of life.  Objective: To describe the association between quality of life and health, anxiety and depression in people who use cardioverter defibrillators. Materials and methods: A qualitative, descriptive, correlational and cross-sectional study was carried out with 85 patients using implantable cardioverter defibrillator.  Sociodemographic records, the Health Questionnaire (SF-36), and the Beck Anxiety and Depression Questionnaire were used.  Results: 81.2% of participants were men with their ages ranging between 36 and 92 years. The health-related quality of life showed a negative correlation with respect to anxiety (r = - 0.622) and a slight correlation with depression (rs = -0.599; p<0.001). Conclusions: The use of a cardioverter-defibrillator can trigger anxiety and depression that can deteriorate the health-related quality of life if not timely intervened. It is important to implement early actions that generate well-being.

References

  1. Organización Mundial de la Salud (OMS). Enfermedades cardiovasculares [Internet]. Centro de prensa. Ginebra: Organización Mundial de la Salud (OMS); 2015. Available from: http://www.who.int/mediacentre/factsheets/fs317/es/
  2. Ministerio de Salud, Instituto Nacional de Salud, Observatorio Nacional de Salud. Carga de enfermedad por enfermedades crónicas no transmisibles y discapacidad en Colombia [Internet]. 5ta ed. Bogotá D.C: Imprenta Nacional de Colombia; 2015. 1–212 p. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/IA/INS/informe-ons-5.pdf
  3. Figueroa-López C, Rocha-Rodríguez V, Cigarroa-López Á, Ramos-Del Río B. Comorbilidad emocional y la aceptación psicológica al desfibrilador automático implantable. Rev Mex Cardiol [Internet]. 2016;27(S1):S4–12. Available from: https://www.medigraphic.com/pdfs/cardio/h-2016/hs161a.pdf
  4. Vázquez Ruiz de Castroviejo E, Muñoz Bellido J, Lozano Cabezas C, Ramírez Moreno A, Guzmán Herrera M, Tarabini Castellani A, et al. Análisis de la frecuencia de las arritmias cardíacas y de los trastornos de conducción desde una perspectiva asistencial. Rev Esp Cardiol [Internet]. 2005;58(6):657–65. Available from: https://doi.org/10.1157/13076418
  5. Borleffs CJW, Van Erven L, Van Bommel RJ, Van Der Velde ET, Van Der Wall EE, Bax JJ, et al. Risk of failure of transvenous implantable cardioverter-defibrillator leads. Circ Arrhythmia Electrophysiol [Internet]. 2009;2(4):411–6. Available from: https://doi.org/10.1161/CIRCEP.108.834093
  6. Dorantes Sánchez M. Complicaciones del cardioversor-desfibrilador automático implantable. Tormenta eléctrica arrítmica. Rev Cuba Investig Biomed [Internet]. 2011;30(4):537–54. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002011000400011
  7. Rodríguez-Morales MM, García-Niebla J, Valle-Racero JI. Intervenciones de enfermería al paciente portador de desfibrilador automático implantable. Cardiocore [Internet]. 2013;48(4):166–9. Available from: https://doi.org/10.1016/j.carcor.2012.10.005
  8. Wong FMF, Sit JWH, Wong EML, Choi KC. Factors associated with health-related quality of life among patients with implantable cardioverter defibrillator: Identification of foci for nursing intervention. J Adv Nurs [Internet]. 2014;70(12):2821–34. Available from: https://doi.org/10.1111/jan.12434
  9. Zuluaga Álzate LJ. Capacidad de agencia de autocuidado y calidad de vida de las personas que tienen dispositivos cardiacos implantables [Internet]. Universidad Nacional de Colombia; 2013:213. Available from: https://repositorio.unal.edu.co/handle/unal/49583
  10. Cevik C, Perez-Verdia A, Nugent K. Implantable cardioverter defibrillators and their role in heart failure progression. Europace [Internet]. 2009;11(6):710–5. Available from: https://doi.org/10.1093/europace/eup091
  11. Lugo LE, Garcia HI, Gomez C. Confiabilidad del cuestionario de calidad de vida en salud SF-36 en Medellin, Colombia. Rev Fac Nac Salud Pública [Internet]. 2006;24(2):37–50. Available from: http://www.scielo.org.co/pdf/rfnsp/v24n2/v24n2a05.pdf
  12. Beck AT, Clark DA. Anxiety and depression: An information processing perspective. Anxiety Res [Internet]. 1988;1(1):23–36. Available from: https://doi.org/10.1080/10615808808248218
  13. Galindo Vázquez O, Rojas Castillo E, Meneses García A, Aguilar Ponce JL, Álvarez Avitia MA, Alvarado Aguilar S. Propiedades psicométricas del inventario de ansiedad de beck (BAI) en pacientes con cáncer. Psicooncología [Internet]. 2015;12(1):51–8. Available from: https://doi.org/10.5209/rev_PSIC.2015.v12.n1.48903
  14. Jurado S, Villegas ME, Méndez L, Rodríguez F, Loperena V, Varela R. La estandarizacion del Inventario de Depresion de Beck para los residentes de la Ciudad de Mexico. Salud Ment [Internet]. 1998;21(3):26–31. Available from: http://www.revistasaludmental.mx/index.php/salud_mental/article/view/706/705
  15. Sears SF, Rosman L, Sasaki S, Kondo Y, Sterns LD, Schloss EJ, et al. Defibrillator shocks and their effect on objective and subjective patient outcomes: Results of the PainFree SST clinical trial. Hear Rhythm [Internet]. 2018;15(5):734–40. Available from: https://doi.org/10.1016/j.hrthm.2017.12.026
  16. Ichikura K, Kobayashi S, Matsuoka S, Suzuki T, Nishimura K, Shiga T, et al. Avoidance behavior associated with depressive symptoms in patients with implantable cardioverter defibrillators. Int J Clin Heal Psychol [Internet]. 2017;17(1):1–8. Available from: https://doi.org/10.1016/j.ijchp.2016.11.001
  17. Mohammadi N, Askari S, Farahani M, Ghorbani A, Ghafarzadegan R. Assessment of anxiety level in patients receiving implantable cardioverter defibrillator. Crescent J Med Biol Sci [Internet]. 2019;6(1):13–7. Available from: http://www.cjmb.org/uploads/pdf/pdf_CJMB_276.pdf
  18. Amiaz R, Asher E, Rozen G, Czerniak E, Glikson M, Amiaz R, et al. Do implantable cardioverter defibrillators contribute to new depression or anxiety symptoms? A retrospective study. Int J Psychiatry Clin Pract [Internet]. 2016;20(2):101–5. Available from: https://doi.org/10.3109/13651501.2016.1161055
  19. Braun S, Krüger J, Souza EN, Rabelo ER. Quality of life of patients with implanted cardiac devices: a transversal study. Online braz j nurs [Internet]. 2012;11(3):778–88. Available from: https://doi.org/10.5935/1676-4285.20120051
  20. Dougherty CM, Fairbanks AM, Eaton LH, Morrison ML, Kim MS, Thompson EA. Comparison of patient and partner quality of life and health outcomes in the first year after an implantable cardioverter defibrillator (ICD). J Behav Med [Internet]. 2016;39(1):94–106. Available from: https://doi.org/10.1007/s10865-015-9671-0
  21. Hammash M, McEvedy SM, Wright J, Cameron J, Miller J, Ski CF, et al. Perceived control and quality of life among recipients of implantable cardioverter defibrillator. Aust Crit Care [Internet]. 2019;32(5):383–90. Available from: https://doi.org/10.1016/j.aucc.2018.08.005
  22. Thylén I, Dekker RL, Jaarsma T, Strömberg A, Moser DK. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients. J Psychosom Res [Internet]. 2014;77(2):122–7. Available from: https://doi.org/10.1016/j.jpsychores.2014.05.007
  23. Elosegui Itxaso L. Calidad de vida en pacientes con Desfibrilador Automático Implantable [Internet]. Tesis de doctorado; Universidad de Zaragoza. 2014. Available from: http://zaguan.unizar.es/record/15780/files/TESIS-2014-074.pdf
  24. Varghese S, Geller JC, Ohlow MA. Phantom shocks in implantable cardioverter-defibrillator recipients: impact of education level, anxiety, and depression. Herzschrittmachertherapie und Elektrophysiologie [Internet]. 2019;30(3):306–12. Available from: https://doi.org/10.1007/s00399-019-00645-y
  25. Varghese S, Geller JC, Ohlow MA. Decision regret in implantable cardioverter-defibrillator recipients: A cross-sectional analysis on patients that regret their decision after ICD implantation. Herzschrittmachertherapie und Elektrophysiologie [Internet]. 2020;31(1):77–83. Available from: https://doi.org/10.1007/s00399-020-00675-x
  26. Pedersen SS, Andersen CM, Denollet J, Habibovic M. Depressive symptoms in patients with an implantable cardioverter defibrillator: Does treatment expectations play a role? Gen Hosp Psychiatry [Internet]. 2018;51(December 2017):10–4. Available from: https://doi.org/10.1016/j.genhosppsych.2017.12.002
  27. Emons WH, Habibović M, Pedersen SS. Prevalence of anxiety in patients with an implantable cardioverter defibrillator: measurement equivalence of the HADS-A and the STAI-S. Qual Life Res [Internet]. 2019;28(11):3107–16. Available from: https://doi.org/10.1007/s11136-019-02237-2
  28. Rottmann N, Skov O, Andersen CM, Theuns DAMJ, Pedersen SS. Psychological distress in patients with an implantable cardioverter defibrillator and their partners. J Psychosom Res [Internet]. 2018;113:16–21. Available from: https://doi.org/10.1016/j.jpsychores.2018.07.010
  29. van Veen B, Andersen CM, Johansen JB, Theuns DA, Pedersen SS. Patient-Reported Quality of Life as a Predictor of Mortality and Ventricular Tachyarrhythmia’s During 7 Years’ Follow-Up in Patients With an Implantable Cardioverter Defibrillator (from the MIDAS Study). Am J Cardiol [Internet]. 2019;123(4):605–10. Available from: https://doi.org/10.1016/j.amjcard.2018.11.021
  30. Berg SK, Rasmussen TB, Mols RE, Thorup CB, Borregaard B, Christensen AV, et al. Both mental and physical health predicts one year mortality and readmissions in patients with implantable cardioverter defibrillators: findings from the national DenHeart study. Eur J Cardiovasc Nurs [Internet]. 2019;18(2):96–105. Available from: https://doi.org/10.1177/1474515118794598
  31. Miller JL, Thylén I, Moser DK. Gender disparities in symptoms of anxiety, depression, and quality of life in defibrillator recipients. PACE [Internet]. 2016;39(2):149–59. Available from: https://doi.org/10.1111/pace.12786
  32. Israelsson J, Thylén I, Strömberg A, Bremer A, Årestedt K. Factors associated with health-related quality of life among cardiac arrest survivors treated with an implantable cardioverter-defibrillator. Resuscitation [Internet]. 2018;132:78–84. Available from: https://doi.org/10.1016/j.resuscitation.2018.09.002
  33. Miller JL, Thylén I, Elayi SC, Etaee F, Fleming S, Czarapata MM, et al. Multi-morbidity burden, psychological distress, and quality of life in implantable cardioverter defibrillator recipients: Results from a nationwide study. J Psychosom Res [Internet]. 2019;120(November 2018):39–45. Available from: https://doi.org/10.1016/j.jpsychores.2019.03.006
  34. Haugaa KH, Potpara TS, Boveda S, Deharo J, Chen J, Dobreanu D, et al. Patients’ knowledge and attitudes regarding living with implantable electronic devices: results of a multicentre, multinational patient survey conducted by the European Heart Rhythm Association. Europace [Internet]. 2018;20:386–91. Available from: https://doi.org/10.1093/europace/eux365
  35. Maron BJ, Casey SA, Olivotto I, Sherrid MV, Semsarian C, Autore C, et al. Clinical Course and Quality of Life in High-Risk Patients with Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Circ Arrhythmia Electrophysiol [Internet]. 2018;11(4):1–9. Available from: https://doi.org/10.1161/CIRCEP.117.005820
  36. Cesarino CB, Beccaria LM, Aroni MM, Rodrigues LCC, Pacheco S da S. Qualidade de vida em pacientes com cardioversor desfibrilador implantável: utilização do questionário SF-36. Rev Bras Cir Cardiovasc [Internet]. 2011;26(2):238–43. Available from: https://doi.org/10.1590/S0102-76382011000200014
  37. Magnusson P, Mörner S, Gadler F, Karlsson J. Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators. Health Qual Life Outcomes [Internet]. 2016;14(62):1–9. Available from: https://doi.org/10.1186/s12955-016-0467-x
  38. Wong FMF. Factors associated with anxiety and depression among patients with implantable cardioverter defibrillator. J Clin Nurs [Internet]. 2017;26(9–10):1328–37. Available from: https://doi.org/10.1111/jocn.13637
  39. Kowey PR, Marinchak RA, Rials SJ. Things that go bang in the night. N Engl J Med [Internet]. 1992;327(26):1884. Available from: https://doi.org/10.1056/NEJM199212243272614

Downloads

Download data is not yet available.